To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
KKR’s Gamma Biosciences makes Astrea deal with Biotage; Inflexion to take dss stake from Gyrus
Inflexion has agreed to buy a majority stake in Swiss operations management consulting firm dss from Gyrus Capital.
